Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 382, Issue 4, pp 385–398 | Cite as

Identification of trace-amine-associated receptors (TAAR) in the rat aorta and their role in vasoconstriction by β-phenylethylamine

  • Martina Fehler
  • Kenneth J. BroadleyEmail author
  • William R. Ford
  • Emma J. Kidd
ORIGINAL ARTICLE

Abstract

Trace amines including tyramine and β-phenylethylamine (β-PEA) increase blood pressure and cause vasoconstriction which is attributed to indirect sympathomimetic actions. However, there is evidence that they may also have non-sympathomimetic mechanisms. This study examined whether β-PEA causes vasoconstriction of rat aorta by a sympathomimetic action or through the recently described trace-amine-associated receptors (TAAR). Concentration–response curves (CRCs) for β-PEA were constructed either cumulatively or non-cumulatively in rat isolated aortic rings. TAAR-1 and TAAR-4 protein expression was determined in rat aorta by Western blotting and TAAR-1 mRNA by reverse transcriptase polymerase chain reaction (RT-PCR). β-PEA caused concentration-related constriction of rat aorta. The contractions were unaffected by endothelium removal or the nitric oxide synthase inhibitor, \( {N_\omega } \)-nitro-l-arginine methyl ester (l-NAME, 100 μM) or the cyclooxygenase inhibitor, indomethacin (10 μM). Non-cumulative CRCs showed greater contractions and sensitivity to β-PEA than cumulative. The α1-adrenoceptor antagonist, prazosin, failed to inhibit either curve. The β-adrenoceptor antagonist, propranolol, the adrenergic neuronal transport inhibitor, cocaine, and the monoamine oxidase inhibitor, pargyline, also failed to alter the CRC. In the combined presence of prazosin, cocaine, pargyline, and the selective β2-adrenoceptor antagonist, ICI-118,551, the trace amine contractile potency order was tryptamine > β-PEA > octopamine > d-amphetamine > tyramine. Western blotting and RT-PCR revealed the presence of TAAR-1 in rat aorta, but TAAR-4 was poorly expressed. Vasoconstriction of rat aorta by β-PEA appears not to be an indirect sympathomimetic action. The presence of TAAR-1 suggests that vasoconstriction may be via these receptors; however, the potency order differed from that reported for transfected cells expressing rat TAAR-1.

Keywords

β-Phenylethylamine Rat aorta Trace amine Vasoconstriction TAAR-1 RT-PCR 

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Al-Motarreb AL, Broadley KJ (2003) Coronary and aortic vasoconstriction by cathinone, the active constituent of khat. Auton Autacoid Pharmacol 23:319–326CrossRefPubMedGoogle Scholar
  2. Al-Motarreb A, Baker K, Broadley KJ (2002) Khat: pharmacological and medical aspects and its social use in Yemen. Phytother Res 16:403–413CrossRefPubMedGoogle Scholar
  3. Anderson R, Ramafi G, Theron AJ (1996) Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils. Biochem Pharmacol 52:341–349CrossRefPubMedGoogle Scholar
  4. Baker KE, Broadley KJ (2003) Vascular actions of ecstasy: role of adrenergic neurones, endothelin, thromboxane, 5-HT, angiotensin and alpha1-receptors. Br J Pharmacol 138:166PGoogle Scholar
  5. Baker KE, Herbert AA, Broadley KJ (2007) Vasoconstriction of porcine left anterior descending coronary artery by ecstasy and cathinone is not an indirect sympathomimetic effect. Vasc Pharmacol 47:10–17CrossRefGoogle Scholar
  6. Berry MD (2004) Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 90:257–271CrossRefPubMedGoogle Scholar
  7. Bilski AJ, Halliday SE, Fitzgerald JD, Wale JL (1983) The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118, 551). J Cardiovasc Pharmacol 5:430–437CrossRefPubMedGoogle Scholar
  8. Bonetta S, Bonetta S, Carraro E, Coisson JD, Travaglia F, Ariorio M (2008) Detection of biogenic amine producer bacteria in a typical Italian goat cheese. J Food Prot 71:205–209PubMedGoogle Scholar
  9. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, Boyle N, Pu X, Kouranova E, Lichtblau H, Ochoa FY, Branchek TA, Gerald C (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A 98:8966–8971CrossRefPubMedGoogle Scholar
  10. Branchek T, Blackburn T (2003) Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol 3:90–97CrossRefPubMedGoogle Scholar
  11. Brawley L, Shaw AM, MacDonald A (2000) Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta. Br J Pharmacol 129:637–644CrossRefPubMedGoogle Scholar
  12. Broadley KJ (1996) Autonomic pharmacology. Taylor & Francis, LondonGoogle Scholar
  13. Broadley KJ (2010) The vascular effects of trace amines and amphetamines. Pharmacol Ther 125:363–375CrossRefPubMedGoogle Scholar
  14. Broadley KJ, Penson PE (2006) Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological properties. Eur J Pharmacol 536:279–286CrossRefPubMedGoogle Scholar
  15. Broadley KJ, Anwar MA, Herbert AA, Fehler M, Jones EM, Davies WE, Kidd EJ, Ford WR (2009) Effects of dietary amines on the gut and its vasculature. Br J Nutr 101:1645–1652CrossRefPubMedGoogle Scholar
  16. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60:1181–1188PubMedGoogle Scholar
  17. Burchett SA, Hicks TP (2006) The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog Neurobiol 79:223–246CrossRefPubMedGoogle Scholar
  18. Day MD (1967) The lack of crossed tachyphylaxis between tyramine and some other indirectly acting sympathomimetic amines. Br J Pharmacol Chemother 30:631–643PubMedGoogle Scholar
  19. Fischer LG, Hollmann MW, Horstman DJ, Rich GF (2000) Cyclooxygenase inhibitors attenuate bradykinin-induced vasoconstriction in septic isolated rat lungs. Anesth Analg 90:625–631CrossRefPubMedGoogle Scholar
  20. Folger WH, Lawson D, Wilcox CS, Mehta JL (1991) Responses of rat thoracic aortic rings to thromboxane mimetic U-46, 619: roles of endothelium-derived relaxing factor and thromboxane A2 release. J Pharmacol Exp Ther 258:669–675PubMedGoogle Scholar
  21. Frascarelli S, Ghelardoni S, Chiellini G, Vargiu R, Ronca-Testoni S, Scanlan TS, Grandy DK, Zucchi R (2008) Eur J Pharmacol 587:231–236CrossRefPubMedGoogle Scholar
  22. Herbert AA, Kidd EJ, Broadley KJ (2008) Dietary trace amine-dependent vasoconstriction in porcine coronary artery. Br J Pharmacol 155:525–534CrossRefPubMedGoogle Scholar
  23. Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533–554CrossRefPubMedGoogle Scholar
  24. Hudgins PM, Fleming WW (1966) A relatively nonspecific super sensitivity in aortic strips resulting from pretreatment with reserpine. J Pharmacol Exp Ther 153:70–80PubMedGoogle Scholar
  25. Kobayashi Y, Zenda H, Chiba S (1992) Existence of beta 1- and beta 2 adrenoceptors in rat abdominal aorta. Asia Pac J Pharm 7:277–281Google Scholar
  26. Krishnamurty VSR, Grollman A (1972) Contractile responses of rat aorta to norepinephrine and tyramine. J Pharmacol Exp Ther 182:264–272PubMedGoogle Scholar
  27. Kuchii M, Shibata S, Mori J (1973) Pharmacological nature of adrenergic innervation in rat aorta. Comp Gen Pharmacol 4:131–138CrossRefPubMedGoogle Scholar
  28. Lefer AM, Smith EF, Araki H, Smith JB, Aharony D, Claremon DA, Magolda RL, Nicolaou KC (1980) Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A 77:1706–1710CrossRefPubMedGoogle Scholar
  29. Lemberger HF, Mason N, Cohen ML (1984) 5HT2 receptors in the rat portal vein: desensitization following cumulative serotonin addition. Life Sci 35:71–77CrossRefPubMedGoogle Scholar
  30. Leung TF, Tang NL, Lam CW, Li AM, Chan IH, Ha G (2002) Thromboxane A2 receptor gene polymorphism is associated with the serum concentration of cat-specific immunoglobulin E as well as the development and severity of asthma in Chinese children. Pediatr Allergy Immunol 13:10–17CrossRefPubMedGoogle Scholar
  31. Lewin AH (2006) Receptors of mammalian trace amines. Aaps 8:E138–E145CrossRefGoogle Scholar
  32. Lindemann L, Hoener MC (2005) A renaissance in trace amines inspired by a novel GPCR family. Trends Pharmacol Sci 26:274–281CrossRefPubMedGoogle Scholar
  33. Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MC (2005) Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85:372–385CrossRefPubMedGoogle Scholar
  34. Maling HM, Fleisch JH, Saul WF (1971) Species differences in aortic responses to vasoactive amines: the effects of compound 48–80, cocaine, reserpine and 6-hydroxydopamine. J Pharmacol Exp Ther 176:672–683PubMedGoogle Scholar
  35. Mao H-M, Chen B-G, Qian X-M, Liu Z (2009) Simultaneous determination of twelve biogenic amines in serum by high performance liquid chromatography. Microchem J 91:176–180CrossRefGoogle Scholar
  36. Marcobal A, de la Rivas B, Muñoz R (2006) First genetic characterization of a bacterial β-phenylethylamine biosynthetic enzyme in Enterococcus faecium RM58. FEMS Microbiol Lett 258:144–149CrossRefPubMedGoogle Scholar
  37. Martinez L, Andres-Trelles F, Hidalgo A (1989) Contraction of various zones of the rat testicular capsule in vitro induced by noradrenaline. Rev Esp Fisiol 45:79–88PubMedGoogle Scholar
  38. Michel M, Wieland T, Tsujimoto G (2009) How reliable are protein-coupled receptor antibodies? Naunyn-Schmiedeberg’s Arch Pharmacol 379:385–388CrossRefGoogle Scholar
  39. Molenaar P, Christ T, Ravens U, Kaumann A (2006) Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart. Cardiovasc Res 69:128–139CrossRefPubMedGoogle Scholar
  40. Murphy DL, Karoum F, Pickar D, Cohen RM, Lipper S, Mellow AM, Tariot PN, Sunderland T (1998) Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline). J Neural Transm Suppl 52:39–48PubMedGoogle Scholar
  41. O’Donnell SR, Wanstall JC (1984a) Beta-1 and beta-2 adrenoceptor-mediated responses in preparations of pulmonary artery and aorta from young and aged rats. J Pharmacol Exp Ther 228:733–738PubMedGoogle Scholar
  42. O’Donnell SR, Wanstall JC (1984b) The classification of beta-adrenoceptors in isolated ring preparations of canine coronary arteries. Br J Pharmacol 81:637–644PubMedGoogle Scholar
  43. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S (1990) Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101:746–752PubMedGoogle Scholar
  44. Rice PJ, Taylor DA, Valinski WA, Head RJ, Fleming WW (1987) Norepinephrine depletion and sensitivity changes in rat heart induced by pretreatment with reserpine. J Pharmacol Exp Ther 240:764–771PubMedGoogle Scholar
  45. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ et al (2004) 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10:638–642CrossRefPubMedGoogle Scholar
  46. Schachter D, Sang JC (1997) Regional differentiation in the rat aorta: effects of cyclooxygenase inhibitors. Am J Physiol 273(3 Pt 2):H1478–H1483PubMedGoogle Scholar
  47. Schonfeld CL, Trendelenburg U (1989) The release of 3H-noradrenaline by p- and m-tyramines and -octopamines, and the effect of deuterium substitution in alpha- position. Naunyn-Schmiedeberg’s Arch Pharmacol 339:433–440CrossRefGoogle Scholar
  48. Smit AJ, Meijer S, Wesseling H, Donker AJ, Reitsma WD (1991) The effects of alpha-adrenoceptor blockade on dopamine-induced renal vasodilation and natriuresis. Naunyn-Schmiedeberg’s Arch Pharmacol 343:143–148CrossRefGoogle Scholar
  49. Smith PL, McCafferty GP, Fondacaro JD, Wasserman MA, Elton E, Ryan FM (1988) Effects of putative thromboxane receptor agonists and antagonists on rat small intestinal ion transport. J Pharmacol Exp Ther 247:143–149PubMedGoogle Scholar
  50. Stanaszek WF, Kellerman D, Brogden RN, Romankiewicz JA (1983) Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs 25:339–384CrossRefPubMedGoogle Scholar
  51. Suzzi G, Gardini F (2003) Biogenic amines in dry fermented sausages: a review. Int J Food Microbiol 88:41–54CrossRefPubMedGoogle Scholar
  52. Thomas RS, Liddell JE, Murphy L, Pache D, Kidd EJ (2006) An antibody to the β-secretase cleavage site on amyloid b-precursor protein inhibits amyloid β production. J Alzheimer’s Dis 10:79–390Google Scholar
  53. Trachte GJ (1986) Thromboxane agonist (U46619) potentiates norepinephrine efflux from adrenergic nerves. J Pharmacol Exp Ther 237:473–477PubMedGoogle Scholar
  54. Trendelenburg U (1972) Classification of sympathomimetic amines. In: Blascho H, Muscholl E (eds) Catecholamines. Handbook of experimental pharmacology, vol 33. Springer, Berlin, pp 336–362Google Scholar
  55. Varma DR, Chemtob S (1993) Endothelium- and beta-2 adrenoceptor-independent relaxation of rat aorta by tyramine and certain other phenylethylamines. J Pharmacol Exp Ther 265:1096–1104PubMedGoogle Scholar
  56. Varma DR, Deng XF, Chemtob S, Nantel F, Bouvier M (1995) Characterization of the vasorelaxant activity of tyramine and other phenylethylamines in rat aorta. Can J Physiol Pharmacol 73:742–746PubMedGoogle Scholar
  57. Zucchi R, Chiellini G, Scanlan TS, Grandy DK (2006) Trace amine-associated receptors and their ligands. Br J Pharmacol 149:967–978CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Martina Fehler
    • 1
  • Kenneth J. Broadley
    • 1
    Email author
  • William R. Ford
    • 1
  • Emma J. Kidd
    • 1
  1. 1.Division of Pharmacology, Welsh School of PharmacyCardiff UniversityCardiffUK

Personalised recommendations